The bid amount that determines what Medicare Part D plans charge is jumping by roughly a quarter for 2027, according to figures the Centers for Medicare & Medicaid Services released this summer. Part of that jump traces directly to a temporary program that has been quietly absorbing some of the cost pressure on standalone drug plans since the benefit’s redesign took effect, and that program is scheduled to disappear after this year. For an older enrollee comparing plans during this fall’s Open Enrollment, understanding why the underlying benchmark moved so sharply matters more than any single plan’s advertised premium.
The Bid Amount That Sets 2027 Drug-Plan Costs
Every year, CMS calculates a national average monthly bid amount, an enrollment-weighted average of what Part D plans say it will cost them to provide the basic drug benefit. That figure feeds directly into the base beneficiary premium formula used across the program. For 2027, CMS set the national average monthly bid amount at $296.05, up from $239.27 in 2026, an increase of about 24 percent in a single year.
A jump of that size in the underlying bid amount would normally translate into a comparable jump in what enrollees pay each month, since the base beneficiary premium is built directly from it. That it has not, at least not in full, is the result of a separate mechanism working in the background of the same bid cycle.
Free retirement updates: Miss an enrollment or claim deadline and it may be gone. Our free Retirement Shield newsletter keeps readers ahead of the ones that matter. Get the free newsletter.
The Stabilization Demonstration Set to Expire After 2026
Since the Inflation Reduction Act reshaped the Part D benefit, CMS has run a Part D Premium Stabilization Demonstration that has helped keep the base beneficiary premium from moving in lockstep with the rising bid amount, giving standalone drug plans a cushion while insurers adjusted to the redesigned benefit structure. The CMS fact sheet confirms the demonstration ends after calendar year 2026, meaning the 2027 bid cycle is the first since the redesign to run without that stabilizing mechanism in place. The timing lines up directly with the sharpest one-year bid increase of the redesign era.
With the demonstration gone, the 24 percent jump in the underlying bid amount has less to absorb it heading into 2028 and beyond, even though a separate statutory limit still caps what individual enrollees see on their monthly bill for 2027 itself.
The 6 Percent Cap Is the Only Thing Holding the Premium Down for 2027
Separate from the now-ending demonstration, the Inflation Reduction Act itself limits how much the base beneficiary premium can grow from one year to the next, capping the increase at 6 percent through 2029. That statutory cap is doing the heavy lifting for 2027: CMS’s own figures show the base beneficiary premium set at $41.33 for 2027, held down by the 6 percent cap, versus an uncapped figure of $94.06 that the bid formula would otherwise produce. The gap between those two numbers, more than $50 a month, shows how much of the underlying cost increase the statutory cap is currently absorbing on enrollees’ behalf.
That cap remains in place through 2029 regardless of what happens to the now-ending demonstration, but it works by capping growth relative to the prior year’s premium, not by capping the bid amount itself. A bid amount that keeps climbing without the demonstration’s cushion puts more pressure on that same 6 percent ceiling in each subsequent year, a dynamic that plays out independently of any single plan’s advertised price for 2027.
Why the National Average Figure Does Not Match Any One Plan’s Bill
None of these national figures describe what a specific enrollee pays. The base beneficiary premium is a benchmark used to calculate government subsidies and the late-enrollment penalty formula, not a price any individual plan is required to charge. Insurers set their own monthly premiums above or below that benchmark depending on their own bid, and the spread between the cheapest and most expensive standalone Part D plans in a given region can run well beyond the $41.33 figure CMS is publishing for 2027. An enrollee comparing plans during Open Enrollment sees the actual premium each plan is charging, not the national average bid amount that determined the underlying subsidy math.
What the rising bid amount does signal is where the cost pressure inside the Part D program is heading once the stabilization demonstration is gone. Plans that priced conservatively while the demonstration offset some of their risk may adjust their bids upward for 2028 once that cushion disappears, even if the statutory 6 percent cap keeps the year-over-year premium increase enrollees actually see within a fixed band for now.
The subsidy programs that sit underneath a Part D premium
A rising benchmark bid matters far less for enrollees already covered by Extra Help, the low-income subsidy that pays part or all of a Part D premium and deductible and caps what a plan can charge per prescription. Medicare Savings Programs run alongside it, covering the Part B premium instead, and enrollment in one of them also qualifies a beneficiary for Extra Help without a second filing. Both turn on income and resource tests rather than on plan pricing, and both are routinely left unclaimed by households that meet the tests but never file the separate paperwork.
The Benefits Checklist is 63 pages across 11 programs, carrying the 2026 income and resource limits for Extra Help and the Medicare Savings Programs and, for each program, the office that handles it in all 50 states.
See the 2026 Extra Help and Medicare Savings Program limits in the Benefits Checklist.
This article was produced with the assistance of AI and reviewed by The Financial Wire editorial team.
David M. Keller is a finance writer based in Columbus, Ohio, covering personal finance and consumer-focused economic topics. He earned his degree in journalism from Ohio University and began his career reporting on local business and economic trends for a regional media outlet. Since then, he has contributed to a variety of online publications, focusing on clear, practical coverage of topics such as cost of living, debt, and everyday financial decision-making.
